Literature DB >> 33766722

Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome.

Shikhar Shrestha1, Melissa H Roberts2, Jessie R Maxwell3, Lawrence M Leeman4, Ludmila N Bakhireva5.   

Abstract

The opioid epidemic in the United States has led to a significant increase in the incidence of neonatal opioid withdrawal syndrome (NOWS); however, the understanding of long-term consequences of NOWS is limited. The objective of this study was to evaluate post-discharge healthcare utilization in infants with NOWS and examine the association between NOWS severity and healthcare utilization. A retrospective cohort design was used to ascertain healthcare utilization in the first year after birth-related discharge using the CERNER Health Facts® database. ICD-9/ICD-10 diagnostic codes were used to identify live births and to classify infants into two study groups: NOWS and uncomplicated births (a 25% random sample). Evaluated outcomes included rehospitalization, emergency department (ED) visits within 30-days and one-year after discharge, and a composite one-year utilization event (either hospitalization or emergency department visit during that year). NOWS severity was operationalized as pharmacologic treatment, length of hospitalization, and medical conditions often associated with NOWS. In 3,526 infants with NOWS (restricted to gestational age ≥ 33 weeks), NOWS severity was associated with an increase in composite one-year utilization (OR: 1.1; 95% CI: 1.04-1.2) after adjusting for prematurity, sepsis, jaundice, use of antibiotics, infant sex, insurance status, race, hospital bed size, year of birth, and census division. In a subset of full-term infants (3008 with NOWS and 88,452 uncomplicated births), having a NOWS diagnosis was associated with higher odds of a 30-day (OR: 1.6; 95% CI: 1.03-2.4) and one-year rehospitalization (OR: 1.6; 95% CI: 1.1-2.4) after adjusting for infant sex, race, type of medical insurance, hospital location, census division, year of primary encounter, hospital bed size, and medical conditions. This study found higher healthcare utilization during the first year of life in infants diagnosed with NOWS, especially those with severe NOWS. Findings suggest a need for closer post-discharge follow-up and management of infants with NOWS.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Healthcare utilization; Hospitalizations; Infants; Neonatal opioid withdrawal syndrome; Opioids; Pregnancy

Mesh:

Year:  2021        PMID: 33766722      PMCID: PMC8277706          DOI: 10.1016/j.ntt.2021.106975

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   4.071


  56 in total

1.  Hospitalisations and out-of-home placements of children of substance-abusing mothers: a register-based cohort study.

Authors:  Kirsimarja Raitasalo; Marja Holmila; Ilona Autti-Rämö; Irma-L Notkola; Heli Tapanainen
Journal:  Drug Alcohol Rev       Date:  2014-03-07

2.  Neonatal abstinence syndrome after methadone or buprenorphine exposure.

Authors:  Hendrée E Jones; Karol Kaltenbach; Sarah H Heil; Susan M Stine; Mara G Coyle; Amelia M Arria; Kevin E O'Grady; Peter Selby; Peter R Martin; Gabriele Fischer
Journal:  N Engl J Med       Date:  2010-12-09       Impact factor: 91.245

Review 3.  Improving the Child Welfare System to Respond to the Needs of Substance-Exposed Infants.

Authors:  Stephen W Patrick; Richard G Frank; Elizabeth McNeer; Bradley D Stein
Journal:  Hosp Pediatr       Date:  2019-07-12

4.  Hospital Readmissions After Pediatric Trauma.

Authors:  Aline B Maddux; Peter E DeWitt; Peter M Mourani; Tellen D Bennett
Journal:  Pediatr Crit Care Med       Date:  2018-01       Impact factor: 3.624

5.  Rehospitalization during the first year of life by insurance status.

Authors:  Nicholas K Schiltz; Beth Finkelstein Rosenthal; Moira A Crowley; Siran M Koroukian; Ann Nevar; Sharon B Meropol; Leona Cuttler
Journal:  Clin Pediatr (Phila)       Date:  2014-06-04       Impact factor: 1.168

6.  Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads.

Authors:  Davida M Schiff; Elisha M Wachman; Barbara Philipp; Kathleen Joseph; Hira Shrestha; Elsie M Taveras; Margaret G K Parker
Journal:  Breastfeed Med       Date:  2018-04-09       Impact factor: 1.817

Review 7.  Neonatal Opioid Withdrawal Syndrome.

Authors:  Stephen W Patrick; Wanda D Barfield; Brenda B Poindexter
Journal:  Pediatrics       Date:  2020-11       Impact factor: 7.124

8.  Opioid prescription claims among women of reproductive age--United States, 2008-2012.

Authors:  Elizabeth C Ailes; April L Dawson; Jennifer N Lind; Suzanne M Gilboa; Meghan T Frey; Cheryl S Broussard; Margaret A Honein
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-01-23       Impact factor: 17.586

9.  Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.

Authors:  Sarah C Haight; Jean Y Ko; Van T Tong; Michele K Bohm; William M Callaghan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-10       Impact factor: 17.586

Review 10.  Review of the assessment and management of neonatal abstinence syndrome.

Authors:  Sarah Mary Bagley; Elisha M Wachman; Erica Holland; Susan B Brogly
Journal:  Addict Sci Clin Pract       Date:  2014-09-09
View more
  3 in total

1.  Prevalence of marijuana use in pregnant women with concurrent opioid use disorder or alcohol use in pregnancy.

Authors:  Kimberly Page; Cristina Murray-Krezan; Lawrence Leeman; Mary Carmody; Julia M Stephen; Ludmila N Bakhireva
Journal:  Addict Sci Clin Pract       Date:  2022-01-06

2.  Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome.

Authors:  Ludmila N Bakhireva; Rajesh C Miranda; Amanda H Mahnke; Melissa H Roberts; Lawrence Leeman; Xingya Ma
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

3.  Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study.

Authors:  Mary Beth Sutter; Hannah Watson; Nicole Yonke; Sherry Weitzen; Lawrence Leeman
Journal:  BMC Pediatr       Date:  2022-06-15       Impact factor: 2.567

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.